Global Pharmatech, Inc. (GBLP)
OTCMKTS · Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST

Global Pharmatech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2007FY 2006FY 2005FY 2004FY 2003
Period Ending
Jun '08 Dec '07 Dec '06 Dec '05 Dec '04 Dec '03
3.182.822.133.091.561.72
Revenue Growth (YoY)
55.57%32.43%-31.00%98.32%-9.60%-
Cost of Revenue
1.711.50.531.40.530.22
Gross Profit
1.471.321.61.691.021.5
Selling, General & Admin
1.751.791.721.560.950.97
Research & Development
0.720.710.690.51-0.390.43
Operating Expenses
3.783.812.872.060.561.4
Operating Income
-2.31-2.49-1.28-0.380.460.1
Interest Expense
-0.23-0.19-0.14-0.19-0.13-0.11
Other Non Operating Income (Expenses)
0.260.180.510.7-0.31
Pretax Income
-2.28-2.5-0.90.130.330.31
Income Tax Expense
---00.020.1
Earnings From Continuing Operations
-2.28-2.5-0.90.130.310.21
Earnings From Discontinued Operations
--0.85-0.22---
Net Income to Company
-2.28-3.35-1.130.130.310.21
Minority Interest in Earnings
0.040.05-0.110.07-00.09
Net Income
-2.24-3.3-1.230.20.310.3
Net Income to Common
-2.24-3.3-1.230.20.310.3
Net Income Growth
----35.28%3.78%-
Shares Outstanding (Basic)
23232218174
Shares Outstanding (Diluted)
23232218174
Shares Change (YoY)
0.05%7.72%22.21%3.15%290.84%-
EPS (Basic)
-0.10-0.14-0.060.010.020.07
EPS (Diluted)
-0.10-0.14-0.060.010.020.07
EPS Growth
----37.26%-73.45%-
Free Cash Flow
0.04-0.57-0.15-2.220.19-1.38
Free Cash Flow Per Share
0.00-0.03-0.01-0.130.01-0.32
Gross Margin
46.24%46.69%75.04%54.62%65.69%87.38%
Operating Margin
-72.55%-88.39%-59.91%-12.29%29.70%6.05%
Profit Margin
-70.45%-117.02%-57.99%6.50%19.93%17.36%
Free Cash Flow Margin
1.39%-20.33%-7.20%-72.08%12.23%-80.44%
EBITDA
-1.81-2.08-0.740.150.880.42
EBITDA Margin
-57.03%-73.63%-34.62%4.90%56.48%24.33%
D&A For EBITDA
0.490.420.540.530.420.31
EBIT
-2.31-2.49-1.28-0.380.460.1
EBIT Margin
-72.55%-88.39%-59.91%-12.29%29.70%6.05%
Effective Tax Rate
---0.90%5.35%31.24%
Advertising Expenses
-0.30.070.170.020.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.